Ho AY, Shiao S, Kobald SA, Chen J, et al. PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer. J Clin Oncol 2024 Sep 19:JCO2400003. doi: 10.1200/JCO.24.00003.
PMID: 39298718